Quest Diagnostics (DGX) has been involved in many strategic development activities. They partnered with Sentara Health Plans to broaden laboratory services in the southeast, supported employee well-being with a remodeled HealthyQuest program, and acquired lab assets from Allina Health and PathAI Diagnostics. Several noteworthy investments have been made into DGX, with XTX Topco Ltd, Hsbc Holdings PLC, and Texas Permanent School Fund all expanding their stake. RGX has also recruited high-profile leaders - Murali Balakumar as CIO, and Robert B. Carter to the board. DGX's innovation is seen in diagnostic services expansion and adoption of AI. They launched a new melanoma test, Melanodal Predict, and gained from customer traction. Their Q2 financials were impressive, leading to a raised outlook for 2024. However, challenges persist with reducing testing sales and competition. Their corporate responsibility initiatives include partnerships with Instacart to reduce food insecurity and a collaboration with Fitbit for metabolic health research.
Quest Diagnostics DGX News Analytics from Tue, 19 Dec 2023 08:00:00 GMT to Sun, 22 Sep 2024 08:49:37 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -4
